salmeterol xinafoate has been researched along with Bronchospasm, Exercise-Induced in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 27 (58.70) | 18.2507 |
| 2000's | 16 (34.78) | 29.6817 |
| 2010's | 3 (6.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonini, M; Israel, E; Kazani, S; Kulkarni, T; Permaul, P; Segal, A; Sorkness, CA; Wechsler, ME | 1 |
| Lipworth, B | 1 |
| Weinberger, M | 1 |
| Matz, J; Ortega, HG; Pearlman, D; Qaqundah, P; Stempel, DA; Yancey, SW | 1 |
| Nishima, S | 1 |
| Balestreri, F; Bertaiola, M; Brotto, E; Ferrari, M; Lo Cascio, V; Segattini, C; Zanon, R | 1 |
| Bauer, CP; Gulyas, A; Steinkamp, G; Trautmann, M; Zimmermann, T | 1 |
| Bjermer, L; Sandsund, M; Steinshamn, S; Sue-Chu, M | 1 |
| Bird, S; Chervinsky, P; Edelman, JM; Ghannam, AF; Hustad, CM; Storms, W | 1 |
| Lyseng-Williamson, KA; Reynolds, NA; Wiseman, LR | 1 |
| Abu-Hasan, M; Weinberger, M | 1 |
| Jones, K | 1 |
| Kradjan, WA; Meyer, JM; Wenzel, CL | 1 |
| Cree, IA; Dhillon, DP; Ingram, CG; Lipworth, BJ; Ramage, L | 1 |
| Bleecker, ER; Busse, WW; Dockhorn, RJ; Kemp, JP; Van As, A | 1 |
| Dhillon, DP; Earnshaw, J; Ingram, CG; Newnham, DM; Palmer, JB | 1 |
| Bratten, G; Henriksen, AH; Schaanning, J; Vilsvik, J | 1 |
| Bratten, G; Carlsen, KH; Leegaard, J; Njå, F; Olsholt, K; Røksund, O | 1 |
| Guill, M | 1 |
| Carroll, NG; Fitch, KD; Joyce, K; Morton, AR; Papalia, SM | 1 |
| de Benedictis, FM; Mezzetti, D; Niccoli, A; Pazzelli, P; Tuteri, G; Vaccaro, R | 1 |
| Cheang, MS; Gerstner, TV; Simons, FE | 1 |
| Kleerup, EC | 1 |
| Auk, IL; Bisgaard, H; Bojsen, K; Ifversen, M; Klug, B; Nielsen, KG | 1 |
| Ciufo, R; McFadden, ER; Nelson, JA; Novak, R; Skowronski, M; Strauss, L | 1 |
| Hansen-Flaschen, J; Schotland, H | 1 |
| Jackson, KM; Lemley, WW | 1 |
| Aziz, I; Lipworth, BJ | 1 |
| Adachi, R; Dickey, BF | 1 |
| Stempel, DA | 1 |
| Morgan, MD; Revill, SM | 1 |
| Kumar, AS | 1 |
| Bronsky, EA; Pearlman, DS; Pobiner, BF; Scott, C; Stahl, E; Wang, Y | 1 |
| Chuchalin, AG; Gunawardena, KA; Helbling, A; Jasan, J; Langley, SJ; Laurenzi, M; Lee, TH; Leff, JA; Menten, J; O'Neill, SJ; Suskovic, S; van Noord, JA; Villaran, C | 1 |
| Bronsky, EA; DeLucca, PT; Edelman, JM; Ghannam, AF; Gormley, GJ; Grossman, J; Kemp, JP; Pearlman, DS; Turpin, JA | 1 |
| Bisgaard, H | 1 |
| Brestel, EP | 1 |
| Burstein-Stein, J; Grieco, AJ | 1 |
| Hendeles, L; Sherman, J | 1 |
| Janicki, S; Jörres, RA; Magnussen, H; Richter, K | 1 |
| Aubert, B; Bons, J; Brambilla, C; de Muizon, H; Godard, P; Guérin, JC | 1 |
| Green, CP; Price, JF | 1 |
| Anderson, SD; Du Toit, J; Rodwell, LT; Young, IH | 1 |
7 review(s) available for salmeterol xinafoate and Bronchospasm, Exercise-Induced
| Article | Year |
|---|---|
[Bronchial asthma in children].
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Androstadienes; Asthma; Asthma, Exercise-Induced; Child; Child, Preschool; Delayed-Action Preparations; Drug Combinations; Fluticasone; Humans; Infant; Leukotriene Antagonists; Nebulizers and Vaporizers; Salmeterol Xinafoate; Severity of Illness Index; Theophylline | 2011 |
Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
Topics: Acetates; Administration, Inhalation; Albuterol; Androstadienes; Asthma; Asthma, Exercise-Induced; Bronchodilator Agents; Budesonide; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Economics, Pharmaceutical; Ethanolamines; Fluticasone; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Humans; Quinolines; Salmeterol Xinafoate; Sulfides; Therapeutic Equivalency | 2005 |
Salmeterol in the management of paediatric asthma.
Topics: Albuterol; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Asthma, Exercise-Induced; Bronchodilator Agents; Child; Child, Preschool; Humans; Salmeterol Xinafoate | 1994 |
Salmeterol: a novel, long-acting beta 2-agonist.
Topics: Adrenergic beta-Agonists; Albuterol; Asthma; Asthma, Exercise-Induced; Bronchodilator Agents; Clinical Trials as Topic; Humans; Salmeterol Xinafoate | 1993 |
Exercise-induced bronchospasm in children: effects and therapies.
Topics: Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Asthma, Exercise-Induced; Bronchodilator Agents; Child; Cromolyn Sodium; Humans; Physical Fitness; Salmeterol Xinafoate | 1996 |
Bronchodilators: new drugs and controversies.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Asthma; Asthma, Exercise-Induced; Bronchoconstriction; Bronchodilator Agents; Drug Monitoring; Humans; Phosphodiesterase Inhibitors; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Theophylline | 1997 |
Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature.
Topics: Administration, Topical; Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Asthma; Asthma, Exercise-Induced; Bronchi; Bronchial Hyperreactivity; Bronchodilator Agents; Child; Double-Blind Method; Drug Combinations; Drug Tolerance; Ethanolamines; Formoterol Fumarate; Glucocorticoids; Humans; Lung; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Status Asthmaticus | 2000 |
23 trial(s) available for salmeterol xinafoate and Bronchospasm, Exercise-Induced
| Article | Year |
|---|---|
Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide.
Topics: Adolescent; Adult; Albuterol; Asthma, Exercise-Induced; Biomarkers; Bronchi; Bronchodilator Agents; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Exercise Test; Female; Genetic Markers; Genotype; Humans; Male; Middle Aged; Nitric Oxide; Polymorphism, Single Nucleotide; Prospective Studies; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Treatment Outcome; Young Adult | 2013 |
Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma.
Topics: Administration, Inhalation; Adolescent; Albuterol; Androstadienes; Asthma, Exercise-Induced; Bronchodilator Agents; Child; Child, Preschool; Drug Combinations; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Salmeterol Xinafoate | 2009 |
Salmeterol versus sodium cromoglycate for the protection of exercise induced asthma in children--a randomised cross-over study.
Topics: Adolescent; Albuterol; Anti-Asthmatic Agents; Asthma, Exercise-Induced; Bronchodilator Agents; Child; Child, Preschool; Cromolyn Sodium; Cross-Over Studies; Exercise; Female; Humans; Lung; Male; Salmeterol Xinafoate | 2003 |
Effects of montelukast and salmeterol on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction.
Topics: Acetates; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Anti-Asthmatic Agents; Asthma, Exercise-Induced; Bronchoconstriction; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Lactates; Male; Pulmonary Gas Exchange; Quinolines; Salmeterol Xinafoate; Sulfides | 2004 |
A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma, Exercise-Induced; Bronchodilator Agents; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Fluticasone; Forced Expiratory Volume; Humans; Middle Aged; Quinolines; Salmeterol Xinafoate; Sulfides; Treatment Outcome | 2004 |
Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Asthma, Exercise-Induced; Bronchodilator Agents; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Salmeterol Xinafoate | 1994 |
Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Analysis of Variance; Asthma, Exercise-Induced; Bronchoconstriction; Bronchodilator Agents; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Salmeterol Xinafoate; Time Factors | 1994 |
Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Asthma, Exercise-Induced; Double-Blind Method; Exercise Test; Female; Forced Expiratory Volume; Humans; Male; Salmeterol Xinafoate; Vital Capacity | 1993 |
Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Asthma, Exercise-Induced; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Exercise Test; Female; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Powders; Salmeterol Xinafoate; Time Factors | 1996 |
Overnight protection by inhaled salmeterol on exercise-induced asthma in children.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Albuterol; Analysis of Variance; Asthma, Exercise-Induced; Bronchoconstriction; Bronchodilator Agents; Child; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Exercise Test; Female; Forced Expiratory Volume; Humans; Lung; Male; Maximal Expiratory Flow Rate; Salmeterol Xinafoate | 1995 |
Is salmeterol ergogenic?
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Anaerobic Threshold; Asthma, Exercise-Induced; Bicycling; Cross-Over Studies; Double-Blind Method; Ergometry; Exercise Test; Hand; Humans; Leg; Lung; Male; Motor Activity; Motor Skills; Muscle Contraction; Muscle, Skeletal; Oxygen Consumption; Physical Exertion; Placebos; Reaction Time; Running; Salmeterol Xinafoate; Swimming | 1996 |
Salmeterol in exercise-induced bronchoconstriction in asthmatic children: comparison of two doses.
Topics: Administration, Inhalation; Adolescent; Albuterol; Asthma; Asthma, Exercise-Induced; Bronchoconstriction; Bronchodilator Agents; Child; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Placebos; Salmeterol Xinafoate | 1996 |
Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Albuterol; Asthma, Exercise-Induced; Beclomethasone; Bronchodilator Agents; Child; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Male; Salmeterol Xinafoate | 1997 |
Clinical effect of Diskus dry-powder inhaler at low and high inspiratory flow-rates in asthmatic children.
Topics: Adolescent; Albuterol; Asthma, Exercise-Induced; Bronchoconstriction; Bronchodilator Agents; Child; Cross-Over Studies; Double-Blind Method; Exercise; Female; Forced Expiratory Volume; Humans; Male; Nebulizers and Vaporizers; Powders; Pulmonary Ventilation; Salmeterol Xinafoate | 1998 |
Effect of long-term salmeterol treatment on exercise-induced asthma.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Asthma, Exercise-Induced; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Tolerance; Female; Forced Expiratory Volume; Humans; Male; Salmeterol Xinafoate; Time Factors | 1998 |
The cardiorespiratory response to submaximal exercise in subjects with asthma following pretreatment with controlled release oral salbutamol and high-dose inhaled salmeterol.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Asthma, Exercise-Induced; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Exercise; Female; Forced Expiratory Volume; Heart Rate; Humans; Male; Middle Aged; Oxygen Consumption; Respiration; Salmeterol Xinafoate | 1998 |
Salmeterol in exercise induced asthma.
Topics: Administration, Inhalation; Adolescent; Albuterol; Asthma, Exercise-Induced; Bronchodilator Agents; Child; Exercise; Humans; Male; Nebulizers and Vaporizers; Peak Expiratory Flow Rate; Placebos; Running; Salmeterol Xinafoate | 1998 |
Prevention of exercise-induced bronchospasm in pediatric asthma patients: A comparison of two salmeterol powder delivery devices.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Asthma, Exercise-Induced; Bronchial Spasm; Child; Child, Preschool; Cross-Over Studies; Double-Blind Method; Exercise Test; Female; Humans; Male; Nebulizers and Vaporizers; Powders; Salmeterol Xinafoate; Time Factors | 1999 |
Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group.
Topics: Acetates; Adolescent; Adult; Albuterol; Asthma, Exercise-Induced; Bronchial Diseases; Bronchodilator Agents; Constriction, Pathologic; Cyclopropanes; Double-Blind Method; Female; Humans; Male; Middle Aged; Quinolines; Salmeterol Xinafoate; Single-Blind Method; Sulfides | 1999 |
Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group.
Topics: Acetates; Administration, Oral; Adolescent; Adult; Albuterol; Area Under Curve; Asthma, Exercise-Induced; Bronchoconstriction; Bronchodilator Agents; Cyclopropanes; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Salmeterol Xinafoate; Sulfides | 2000 |
Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Asthma, Exercise-Induced; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Ethanolamines; Female; Formoterol Fumarate; Humans; Male; Middle Aged; Pulmonary Ventilation; Salmeterol Xinafoate; Spirometry; Terbutaline; Time Factors | 2002 |
[Prolonged effect against exercise-induced bronchospasm: salmeterol versus sodium cromoglycate].
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Asthma, Exercise-Induced; Cromolyn Sodium; Double-Blind Method; Female; Humans; Male; Salmeterol Xinafoate; Time Factors | 1992 |
Prevention of exercise induced asthma by inhaled salmeterol xinafoate.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Antagonists; Albuterol; Analysis of Variance; Asthma, Exercise-Induced; Bronchodilator Agents; Child; Double-Blind Method; Drug Evaluation; Female; Forced Expiratory Volume; Humans; Male; Regression Analysis; Salmeterol Xinafoate; Time Factors | 1992 |
16 other study(ies) available for salmeterol xinafoate and Bronchospasm, Exercise-Induced
| Article | Year |
|---|---|
β-Adrenoceptor genotype and bronchoprotective subsensitivity with long-acting β-agonists in asthma.
Topics: Albuterol; Asthma, Exercise-Induced; Bronchodilator Agents; Drug Tolerance; Female; Humans; Male; Nitric Oxide; Polymorphism, Single Nucleotide; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate | 2013 |
Long-acting beta-agonists and exercise.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Asthma, Exercise-Induced; Bronchodilator Agents; Ethanolamines; Exercise; Formoterol Fumarate; Humans; Salmeterol Xinafoate; Sports | 2008 |
Comparison of the protective effect of formoterol and of salmeterol against exercise-induced bronchospasm when given immediately before a cycloergometric test.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Asthma, Exercise-Induced; Child; Cross-Over Studies; Double-Blind Method; Ethanolamines; Exercise Test; Female; Formoterol Fumarate; Humans; Male; Salmeterol Xinafoate; Treatment Outcome | 2002 |
Life-threatening asthma during treatment with salmeterol.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Albuterol; Androstadienes; Asthma; Asthma, Exercise-Induced; Bronchodilator Agents; Budesonide; Drug Therapy, Combination; Ethanolamines; Fluticasone; Humans; Male; Salmeterol Xinafoate | 2006 |
New treatments for exercise-induced asthma.
Topics: Acetates; Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Asthma, Exercise-Induced; Bronchoconstriction; Cyclopropanes; Drug Tolerance; Humans; Leukotriene Antagonists; Quinolines; Salmeterol Xinafoate; Sulfides | 1998 |
The 'focus' on asthma too focused.
Topics: Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Asthma, Exercise-Induced; Humans; Manipulation, Orthopedic; Salmeterol Xinafoate | 1998 |
Exercise-induced asthma.
Topics: Acetates; Albuterol; Asthma, Exercise-Induced; Bronchodilator Agents; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Salmeterol Xinafoate; Sulfides | 1998 |
Exercise-induced asthma.
Topics: Adrenergic beta-Agonists; Albuterol; Asthma, Exercise-Induced; Bronchoconstriction; Cold Temperature; Confounding Factors, Epidemiologic; Drug Tolerance; Humans; Salmeterol Xinafoate | 1998 |
Exercise-induced asthma.
Topics: Adrenergic beta-Agonists; Albuterol; Asthma, Exercise-Induced; Drug Tolerance; Humans; Salmeterol Xinafoate | 1998 |
Exercise-induced asthma.
Topics: Acetates; Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Area Under Curve; Asthma, Exercise-Induced; Cold Temperature; Cyclopropanes; Forced Expiratory Volume; Humans; Humidity; Quinolines; Salmeterol Xinafoate; Sulfides | 1998 |
Oral montelukast versus inhaled salmeterol to prevent exercise-induced bonchonconstriction.
Topics: Acetates; Albuterol; Anti-Asthmatic Agents; Asthma, Exercise-Induced; Bronchodilator Agents; Cyclopropanes; Ethics, Medical; Humans; Quinolines; Salmeterol Xinafoate; Sulfides | 2000 |
Oral montelukast versus inhaled salmeterol to prevent exercise-induced bronchoconstriction.
Topics: Acetates; Aged; Albuterol; Anti-Asthmatic Agents; Asthma, Exercise-Induced; Bronchodilator Agents; Chemical and Drug Induced Liver Injury; Cyclopropanes; Female; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Tosyl Compounds | 2000 |
Practical pharmacotherapy for pediatric asthma.
Topics: Albuterol; Asthma; Asthma, Exercise-Induced; Bronchodilator Agents; Budesonide; Child; Glucocorticoids; Humans; Leukotrienes; Salmeterol Xinafoate; Theophylline | 2000 |
Formoterol (Foradil Aerolizer) for asthma.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aerosols; Albuterol; Asthma; Asthma, Exercise-Induced; Atrial Premature Complexes; Bronchial Spasm; Bronchodilator Agents; Child, Preschool; Clinical Trials as Topic; Ethanolamines; Formoterol Fumarate; Humans; Salmeterol Xinafoate; Tachycardia | 2001 |
[Exercise-induced asthma. Prevention with long-term effect is preferred].
Topics: Acetates; Adolescent; Albuterol; Asthma, Exercise-Induced; Child; Cyclopropanes; Drug Administration Schedule; Humans; Quinolines; Salmeterol Xinafoate; Sulfides; Treatment Outcome | 2002 |
Duration of protection by inhaled salmeterol in exercise-induced asthma.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Asthma, Exercise-Induced; Exercise Test; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Salmeterol Xinafoate | 1991 |